Discovery and Development of SQ109: A New Antitubercular Drug with a Novel Mechanism of Action
-
- Katherine A Sacksteder
- Sequella, Inc., Rockville, MD, USA
-
- Marina Protopopova
- Sequella, Inc., Rockville, MD, USA
-
- Clifton E Barry
- Tuberculosis Research Section, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
-
- Koen Andries
- Antimicrobial Research, Janssen Infectious Diseases, Beerse, Belgium
-
- Carol A Nacy
- Sequella, Inc., Rockville, MD, USA
収録刊行物
-
- Future Microbiology
-
Future Microbiology 7 (7), 823-837, 2012-07
Informa UK Limited